Margatoxin inhibits VEGF-induced hyperpolarization, proliferation and nitric oxide production of human endothelial cells

Journal of Vascular Research

Volumn 42, Issue 5, 2005, Pages 368-376

  Erdogan, Ali ^a   Schaefer, Christian Alexander ^a   Schaefer, Matthias ^a   Luedders, Doerte Wiebke ^a   Stockhausen, Florian ^a   Abdallah, Yaser ^a   Schaefer, Claudia ^a   Most, Astrid Kerstin ^a   Tillmanns, Harald ^a   Piper, Hans Michael ^a   Kuhlmann, Christoph Ruediger Wolfram ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

2 Aminoethoxydiphenyl borate; Calcium; Endothelial cells; Fluorescence imaging; Hyperpolarization; K+ channels; Margatoxin; Nitric oxide; Proliferation; Vascular endothelial growth factor

Indexed keywords

FURA 2; MARGATOXIN; NITRIC OXIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; THYMIDINE; VASCULOTROPIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL COUNT; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM CELL; EXTRACELLULAR CALCIUM; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HYPERPOLARIZATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

CALCIUM; CELL DIVISION; CELL POLARITY; CELL SURVIVAL; CELLS, CULTURED; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; KV1.3 POTASSIUM CHANNEL; NEUROTOXINS; NITRIC OXIDE; OMEGA-N-METHYLARGININE; POTASSIUM CHANNELS, VOLTAGE-GATED; SCORPION VENOMS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 25444478574     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087159     Document Type: Article

References (38)

1. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
2. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
3. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 1992;187:1579-1586.
4. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine, a receptor for vascular endothelial growth factor. Science 1992;255:989-991.
5. Risau W: Mechanisms of angiogenesis. Nature 1997;386:671-674.
6. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature 1995;1:27-31.
7. Waltenberger J: Modification of growth factor action. Implications for the treatment of cardiovascular diseases. Circulation 1997;96:4083-4095.
8. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-985.
9. Lopez JJ, Laham RJ, Carrozza JP, Tofukuji M, Sellke FW, Bunting S, Simons M: Haemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response. Am J Physiol 1997;273:1317-1323.
10. Horowitz JR, Rivard A, van der Zee R, Hariawala M, Sheriff DD, Esakhof DD, Chaudhry GM, Symes JF, Isner JM: Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Atheroscler Thromb Vasc Biol 1997;17:2793-2800.
11. Adams DJ, Barakeh J, Laskey R, van Breemen C: Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 1989;3:2389-2400.
12. Colden-Stanfield M, Schilling WP, Ritchie AK, Eskin SG, Navarro LT, Kunze DL: Bradykinin-induced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells. Circ Res 1987;61:632-640.
13. Li L, Bressler B, Prameya K, Dorovini-Zis K, van Breemen C: Agonist-stimulated calcium entry in primary cultures of human microvascular endothelial cells. Microvasc Res 1999;57:211-226.
14. Nilius B, Droogmans G: Ion channels and their functional role in vascular endothelium. Physiol Rev 2001;81:1415-1459.
15. Solthoff SP, Cantley LC: Mitogens and ion fluxes. Annu Rev Physiol 1988;50:207-223.
16. Nilius B, Viana F, Droogmans G: Ion channels in vascular endothelium. Annu Rev Physiol 1997;59:145-170.
17. Cheng GF, Cheung DW: Characterization of acetylcholine-induced membrane hyperpolarization in endothelial cells. Circ Res 1992;70:257-263.
18. + channels in cell proliferation. News Physiol Sci 1994;9:105-110.
19. + channels inhibits proliferation of human endothelial cells induced by basic fibroblast growth factor. J Vasc Res 1998;35:363-371.
20. + channels by oxidized LDL and its contribution to endothelial proliferation. Cardiovasc Res 2003;60:626-634.
21. + current. Arterioscler Thromb Vasc Biol 2004;24:1229-1233.
22. Kuhlmann CRW, Gast C, Li F, Schäfer M, Tillmanns H, Waldecker B, Wiecha J: Cerivastatin activates endothelial calcium-activated potassium channels and thereby modulates endothelial NO production and cell proliferation. J Am Soc Nephrol 2004;15:868-875.
23. + channels in human endothelial cells in culture. Int J Biochem Cell Biol 2001;33:337-346.
24. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 1991;138:213-221.
25. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology (review). Pharmacol Rev 1991;43:109-142.
26. Morbidelli L, Chang CH, Douglas JG: Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996;270:H411-H415.
27. van der Zee RT, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM: Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997;95:1030-1037.
28. + channel openers and glucose deprivation. J Physiol 1997;502:397-408.
29. 2+ entry by IGF-1 in human embryonic kidney cells. Pflügers Arch 2002;445:74-79.
30. Garcia-Calvo M, Leonard RJ, Novick J, Stevens SP, Schmalhofer W, Kaczorowski GJ, Garcia ML: Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J Biol Chem 1993;282:18866-18874.
31. Cheoung A, Dedman AM, Xu SZ, Beech DJ: K(V)alpha1 channels in murine arterioles: differential cellular expression and regulation of diameter. Am J Physiol Heart Circ Physiol 2001;281:H1057-H1065.
32. Vaca L, Licea A, Possani LD: Modulation of cell membrane potential in cultured vascular endothelium. Am J Physiol 1996;270:C819-C824.
33. Luckhoff A, Busse R: Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential. Pflügers Arch 1990;416:305-311.
34. 2+ entry in vascular endothelial cells is mediated via pathways sensitive to 2 aminoethoxydiphenyl borate and xestospongin C. Br J Pharmacol 2002;135:119-128.
35. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC: Nitrix oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997;12:3131-3139.
36. Ziehe M, Morbidelli R, Choudhuri HT, Zhang HT, Donnimi S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997;99:2625-2634.
37. + channels via PI3-kinase, PDK1 and SGK1. Pflugers Arch 2002;443:625-634.
38. Khanna R, Chang MC, Joiner WJ, Kaczmarek LK, Schlichter LC: hSK4/hlK1, a calmodulin-binding KCa channel in human T lymphocytes. Roles in proliferation and volume regulation. J Biol Chem 1999;274:14838-14849.